- Filed
- Mar 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 11, 2025 | 62.23M sh |
| Long Term Debt | Q1 2025 · Jan 31, 2025 | $1.51B |
| Long Term Debt | Q1 2025 · Oct 31, 2024 | $1.3B |
| Short Term Debt | Q1 2025 · Jan 31, 2025 | $31.6M |
| Short Term Debt | Q1 2025 · Oct 31, 2024 | $31.6M |
| Cash And Equivalents | Q1 2025 · Jan 31, 2025 | $59M |
| Cash And Equivalents | Q1 2025 · Oct 31, 2024 | $64.6M |
| Current Liabilities | Q1 2025 · Jan 31, 2025 | $1.26B |
| Current Liabilities | Q1 2025 · Oct 31, 2024 | $1.35B |
| Total Liabilities | Q1 2025 · Jan 31, 2025 | $3.44B |
| Total Liabilities | Q1 2025 · Oct 31, 2024 | $3.32B |
| Current Assets | Q1 2025 · Jan 31, 2025 | $1.92B |
| Current Assets | Q1 2025 · Oct 31, 2024 | $1.79B |
| Total Assets | Q1 2025 · Jan 31, 2025 | $5.22B |
| Total Assets | Q1 2025 · Oct 31, 2024 | $5.1B |
| Stockholders Equity | Q1 2025 · Oct 31, 2024 | $1.78B |
| Stockholders Equity | Q1 2025 · Jan 31, 2024 | $1.82B |
| Shares Diluted | Q1 2025 · Jan 31, 2024 | 63.9M sh |
| Stock Repurchased | Q1 2025 · Jan 31, 2024 | $0 |
| Dividends Paid | Q1 2025 · Jan 31, 2024 | $14.1M |
| Capex | Q1 2025 · Jan 31, 2024 | $13.6M |
| Operating Cash Flow | Q1 2025 · Jan 31, 2024 | −$100K |
| Eps Diluted | Q1 2025 · Jan 31, 2024 | $0.70 |
| Eps Basic | Q1 2025 · Jan 31, 2024 | $0.70 |
| Sga Expense | Q1 2025 · Jan 31, 2024 | $154.6M |
| Net Income | Q1 2025 · Jan 31, 2024 | $44.7M |
| Operating Income | Q1 2025 · Jan 31, 2024 | $74.1M |
| Cost Of Revenue | Q1 2025 · Jan 31, 2024 | $1.83B |
| Revenue | Q1 2025 · Jan 31, 2024 | $2.07B |